Showing results (111-120 of 118) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Facial Plastic Surgery & Aesthetic Medicine|April 17, 2026
Features of Importance in the Nasal Exam in RhinoplastyElizabeth S Longino, Cherian K Kandathil, Jamil Ahmad, et al.Veterinary Parasitology|August 15, 2000
Efficacy of selamectin against experimentally induced and naturally acquired ascarid (Toxocara canis and Toxascaris leonina) infections in dogsT L McTier, E M Siedek, R G Clemence, et al.Journal of Psychopharmacology (Oxford, England)|January 12, 2008
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteersS L de Haas, S J de Visser, J P van der Post, et al.Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.Clinical Pharmacology and Therapeutics|January 27, 2012
A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable anginaB R Chaitman, A P Ho, M O Behm, et al.Journal of Psychopharmacology (Oxford, England)|November 10, 2006
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteersS L de Haas, S J de Visser, J P van der Post, et al.Clinical Pharmacology and Therapeutics|June 29, 2012
Equivalent dynamic human brain NK1-receptor occupancy following single-dose i.v. fosaprepitant vs. oral aprepitant as assessed by PET imagingK Van Laere, J De Hoon, G Bormans, et al.Journal of Psychopharmacology (Oxford, England)|February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonistJ R Atack, D J Hallett, S Tye, et al.Pageof 12